Metalloporphyrins for the treatment of neonatal jaundice

Current Opinion in Pediatrics

Volumn 17, Issue 2, 2005, Pages 167-169

  Dennery, Phyllis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Heme oxygenase; Hemolysis; Kernicterus; Metalloporphyrin; Neonatal hyperbilirubinemia

Indexed keywords

BILIRUBIN; CHROMIUM MESOPORPHYRIN; HEME OXYGENASE 1; METALLOPORPHYRIN; PLACEBO; PROTOPORPHYRIN TIN; PROTOPORPHYRIN ZINC; UNCLASSIFIED DRUG;

BILIRUBIN BLOOD LEVEL; CARCINOGENICITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ERYTHEMA; HUMAN; INTRAUTERINE GROWTH RETARDATION; IRON DEFICIENCY ANEMIA; LEAD POISONING; LONG TERM CARE; LUNG FIBROSIS; NEWBORN JAUNDICE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; TREATMENT FAILURE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

BILIRUBIN; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; METALLOPORPHYRINS; MOLECULAR STRUCTURE; TREATMENT OUTCOME;

EID: 17144394163     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000156270.25640.5a     Document Type: Review

References (22)

1. Lucey J, Ferriero M, Hewitt J. Prevention of hyperbilirubinemia of prematurity by phototherapy. Pediatrics 1968; 41:1047-1054.
2. Diamond LK, Allen FH Jr, Thomas WO Jr. Erythroblastosis fetalis: VII. Treatment with exchange transfusion. N Engl J Med 1951; 244:39.
3. Yaffe SJ, Levy G, Matsuzawa T, et al. Enhancement of glucuronide- conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med 1966; 275:1461-1466.
4. Kappas A, Drummond GS, Manola T, et al. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988; 81:485-497.
5. Valaes T, Petmezaki S, Henschke C, et al. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 1994; 93:1-11.
6. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 1998; 101:E1.
7. Martinez JC, Garcia HO, Otheguy LE, et al. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999; 103:1-5.
8. Kappas A, Drummond GS, Munson DP, et al. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001; 108:1374-1377.
9. Reddy P, Najundaswamy S, Mehta R, et al. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. J Perinatol 2003; 23:507-508. This case report illustrates the efficacy of a single dose of SnMP in reducing serum bilirubin in a neonate with intrauterine growth retardation after failure of intensive phototherapy.
10. Juul SE, Zerzan JC, Strandjord TP, et al. Zinc protoporphyrin/heme as an indicator of iron status in NICU patients. J Pediatr 2003; 142:273-278. ZnPP is an endogenous metalloporphyrin, which serves as an important index of iron status in the erythrocyte. This study demonstrates that expression of ZnPP is inversely correlated with gestational age in humans.
11. Vreman HJ, Rodgers PA, Stevenson DK. Zinc protoporphyrin administration for suppression of increased bilirubin production by iatrogenic hemolysis in rhesus neonates. J Pediatr 1990; 117:292-297.
12. Yang G, Nguyen X, Ou J, et al. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis. Blood 2001; 97:1306-1313.
13. Fang J, Sawa T, Akaike T, et al. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 2004; 109:1-8. The potential for ZnPP to prevent tumor proliferation suggests that this compound may pose a risk in neonates with rapidly proliferating tissues.
14. Fang J, Sawa T, Akaike T, et al. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003; 63:3567-3574. The potential for ZnPP to prevent tumor proliferation suggests that this compound may pose a risk in neonates with rapidly proliferating tissues.
15. Akins R Jr, McLaughlin T, Boyce R, et al. Exogenous metalloporphyrins alter the organization and function of cultured neonatal rat heart cells via modulation of heme oxygenase activity. J Cell Physiol 2004; 201:26-34. If metalloporphyrins modify cardiac cell function in humans, this could lead to serious adverse consequences.
16. Atzori L, Chua F, Dunsmore SE, et al. Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol. Thorax 2004; 59:217-223. Unlike ZnPP, ZnBG may be protective against pulmonary fibrosis.
17. Hajdena-Dawson M, Zhang W, Contag PR, et al. Effects of metalloporphyrins on heme oxygenase-1 transcription: correlative cell culture assays guide in vivo imaging. Mol Imaging 2003; 2:138-149.
18. Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 1993; 33:195-200.
19. Park RM, Bena JF, Stayner LT, et al. Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment. Risk Anal 2004; 24:1099-1108.
20. Davidson T, Kluz T, Burns F, et al. Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol Appl Pharmacol 2004; 196:431-437.
21. Dani C, Masini E, Bertini G, et al. Role of heme oxygenase and bilirubin in oxidative stress in preterm infants. Pediatr Res 2004; 56:873-877.
22. Zampetaki A, Minamino T, Mitsialis SA, et al. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med (Maywood) 2003; 228:442-446. When suppression of heme oxygenase-1 is contemplated, it is important to consider the beneficial properties of this enzyme against inflammation and oxidative stress.